naltrexone drug
Evidence from:
primary |
all sources
Related entities (77)
Mentioned in (30)
Papers in which this entity is mentioned.
- Emotion, motivation, decision-making, the orbitofrontal cortex, anterior cingulate cortex, and the amygdala. (2023)
- Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
- Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
- Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
- Sex/gender differences in brain function and structure in alcohol use: A narrative review of neuroimaging findings over the last 10 years. (2021)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Hypermethylation of Proopiomelanocortin and Period 2 Genes in Blood Are Associated with Greater Subjective and Behavioral Motivation for Alcohol in Humans. (2019)
- The neural correlates of the unified percept of alcohol-related craving: a fMRI and EEG study. (2018)
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018)
- Genetic studies of alcohol dependence in the context of the addiction cycle. (2017)
- Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. (2017)
- Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits. (2017)
- Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. (2015)
- Pharmacogenetics of OPRM1. (2014)
- Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. (2014)
- Effects of alcohol on the endocrine system. (2013)
- Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. (2012)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012)
- The genetic basis of addictive disorders. (2012)
- The genetics of the opioid system and specific drug addictions. (2012)
- A genetic determinant of the striatal dopamine response to alcohol in men. (2011)
- Haplotype block structure of the genomic region of the mu opioid receptor gene. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Assessment of benefits of a universal screen for maternal alcohol use during pregnancy. (2010)
- Consilient research approaches in studying gene x environment interactions in alcohol research. (2010)
- Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond. (2009)
- Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study. (2009)
- Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. (2009)
- Brief intervention in primary care settings. A primary treatment method for at-risk, problem, and dependent drinkers. (1999)
- The role of stress in alcohol use, alcoholism treatment, and relapse. (1999)
Merged raw entities (7)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| naltrexone | drug | 29 | 109 |
| long-acting naltrexone | drug | 1 | 1 |
| opioid receptor antagonist | drug | 1 | 2 |
| oral naltrexone | drug | 1 | 1 |
| mor antagonist naltrexone | drug | — | — |
| opiate antagonist | drug | — | — |
| opioid antagonist naltrexone | drug | — | — |